Unique Issues Facing Brand-Compounder Patent Litigation
Recent developments involving compounded GLP-1 tablet products have fostered questions about compounding pharmacies as new and substantial sources of prescription drugs, and whether intellectual property disputes may increase....To view the full article, register now.
Already a subscriber? Click here to view full article